CRIM1 and breast cancer: This analysis revealed significant differences in the abundance of MSigDB collections (c2.cp.v7.2.symbols.gmt) and that M phase, metabolism of amino acids and derivatives were remarkably differentially enriched in samples with low CRIM1 levels (Figures 7A, B), indicating that low CRIM1 levels may influence breast cancer development via these pathways.